168 138

Cited 1 times in

Clinical implication of the 2020 International Association for the Study of Lung Cancer histologic grading in surgically resected pathologic stage 1 lung adenocarcinomas: Prognostic value and association with computed tomography characteristics

DC Field Value Language
dc.contributor.author서영주-
dc.contributor.author심효섭-
dc.contributor.author이혜정-
dc.date.accessioned2023-11-07T07:51:37Z-
dc.date.available2023-11-07T07:51:37Z-
dc.date.issued2023-10-
dc.identifier.issn0169-5002-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/196542-
dc.description.abstractObjectives: To investigate the incremental prognostic value of the 2020 International Association for the Study of Lung Cancer (IASLC) histologic grading system over traditional prognosticators in surgically resected pathologic stage 1 lung adenocarcinomas and to identify the clinical and radiologic characteristics of lung adenocarcinomas reclassified by the 2020 histologic grading system. Materials and methods: We retrospectively enrolled 356 patients who underwent surgery for pathologic stage 1 adenocarcinoma between January 2016 and December 2017. The histologic grading was classified according to the predominant histologic subtype (conventional system) and the updated 2020 IASLC grading system. The clinical and computed tomography (CT) characteristics were compared according to the reclassification of the updated system. The performance of prognostic models for recurrence-free survival based on the combination of pathologic tumor size, histologic grade, and CT-based information was compared using the c-index. Results: Postoperative recurrence occurred in 6.7% of patients during the follow-up period (mean, 1589.2 ± 406.7 days). Fifty-nine of 244 (24.2%) tumors with intermediate grades in the conventional system were reclassified as grade 3 with the updated grading system. They showed significantly larger solid proportions and higher percentages of pure solid nodules on CT compared to tumors without reclassification (n = 185) (P < 0.05). Prognostic prediction models based on pathology tumor size and histologic grades had significantly higher c-indices (0.754-0.803) compared to the model based on pathologic tumor size only (c-index:0.723, P < 0.05). Conclusion: The 2020 IASLC histologic grading system has significant incremental prognostic value over the pathologic stage in surgically resected pathologic stage 1 lung adenocarcinoma. Reclassified lung adenocarcinomas using the updated grading system have a larger solid proportion and a higher percentage of pure solid nodules on CT.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherElsevier Scientific Publishers-
dc.relation.isPartOfLUNG CANCER-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHAdenocarcinoma of Lung* / diagnostic imaging-
dc.subject.MESHAdenocarcinoma of Lung* / surgery-
dc.subject.MESHHumans-
dc.subject.MESHLung Neoplasms* / diagnostic imaging-
dc.subject.MESHLung Neoplasms* / surgery-
dc.subject.MESHPrognosis-
dc.subject.MESHRetrospective Studies-
dc.subject.MESHTomography, X-Ray Computed-
dc.titleClinical implication of the 2020 International Association for the Study of Lung Cancer histologic grading in surgically resected pathologic stage 1 lung adenocarcinomas: Prognostic value and association with computed tomography characteristics-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Radiology (영상의학교실)-
dc.contributor.googleauthorIn Sung Cho-
dc.contributor.googleauthorHyo Sup Shim-
dc.contributor.googleauthorHye-Jeong Lee-
dc.contributor.googleauthorYoung Joo Suh-
dc.identifier.doi10.1016/j.lungcan.2023.107345-
dc.contributor.localIdA01892-
dc.contributor.localIdA02219-
dc.contributor.localIdA03320-
dc.relation.journalcodeJ02174-
dc.identifier.eissn1872-8332-
dc.identifier.pmid37611496-
dc.subject.keywordCT characteristics-
dc.subject.keywordHistologic subtype-
dc.subject.keywordLung adenocarcinoma-
dc.subject.keywordPrognosis-
dc.contributor.alternativeNameSuh, Young Joo-
dc.contributor.affiliatedAuthor서영주-
dc.contributor.affiliatedAuthor심효섭-
dc.contributor.affiliatedAuthor이혜정-
dc.citation.volume184-
dc.citation.startPage107345-
dc.identifier.bibliographicCitationLUNG CANCER, Vol.184 : 107345, 2023-10-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pathology (병리학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Radiology (영상의학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.